RFL
Rafael Holdings, Inc.
Key Financials
Net Income
$-30520000
↓ 10424.1%
Revenue
$917000
↑ 44.0%
EPS (Diluted)
$-1.04
↑ 28.3%
Total Liabilities
$15.7M
↑ 48.8%
Shareholders' Equity
$94.4M
↑ 14.9%
Cash & Equivalents
$52.8M
↑ 1872.7%
Operating Income
$-29159000
↑ 71.6%
Operating Cash Flow
$-18924000.00
↓ 142.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 7/31/2026 | View on SEC |
| 8-K | 7/8/2026 | View on SEC |
| 4 | 6/23/2026 | View on SEC |
| 4 | 6/16/2026 | View on SEC |
| 10-Q | 6/11/2026 | View on SEC |
| 8-K | 6/11/2026 | View on SEC |
| 8-K | 6/10/2026 | View on SEC |
| 8-K | 4/22/2026 | View on SEC |
| 4 | 3/24/2026 | View on SEC |
| 4 | 3/17/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | RFL |
| Company Name | Rafael Holdings, Inc. |
| CIK | 1713863 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | NYSE |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0731 |
| State of Incorporation | DE |
| Phone | 212-658-1450 |